The global Hip Tendinitis market was valued at US$ 296.9 million in 2023 and is projected to reach US$ 412.3 million by 2030, at a CAGR of 4.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Internal Snapping Hip Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Hip Tendinitis include Almatica Pharma, AstraZeneca, Bayer, Boehringer Ingelheim Pharmaceuticals, Merck & Co., Pfizer, Abbott, GlaxoSmithKline and Teva Pharmaceuticals, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Hip tendinitis is an uncomfortable inflammatory condition when a tendon in the hip becomes iritated or inflamed. Other names for it include hip tendonitis and hip flexor tendonitis. The rapidly increasing rate of the senior population worldwide and growing sports activities are primarily increasing the demand for hip tendonitis treatment.
This report aims to provide a comprehensive presentation of the global market for Hip Tendinitis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hip Tendinitis. This report contains market size and forecasts of Hip Tendinitis in global, including the following market information:
- Global Hip Tendinitis Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global top five companies in 2023 (%)
We surveyed the Hip Tendinitis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hip Tendinitis Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Hip Tendinitis Market Segment Percentages, by Type, 2023 (%)
- Internal Snapping Hip
- External Snapping Hip
- Intra-articular Snapping Hip
Global Hip Tendinitis Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Hip Tendinitis Market Segment Percentages, by Application, 2023 (%)
- Hospitals & Clinics
- Medical Research Centers
- Academic Institutes
- Others
Global Hip Tendinitis Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Hip Tendinitis Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Hip Tendinitis revenues in global market, 2019-2024 (estimated), ($ millions)
- Key companies Hip Tendinitis revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Almatica Pharma
- AstraZeneca
- Bayer
- Boehringer Ingelheim Pharmaceuticals
- Merck & Co.
- Pfizer
- Abbott
- GlaxoSmithKline
- Teva Pharmaceuticals
- Lupin Pharmaceuticals
- Geri-Care Pharmaceuticals
- Perrigo Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hip Tendinitis, market overview.
Chapter 2: Global Hip Tendinitis market size in revenue.
Chapter 3: Detailed analysis of Hip Tendinitis company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hip Tendinitis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
